Results for: Obesity

Tony Genua, a seasoned portfolio manager with over four decades of experience, shares his insights on the US market and highlights his bullish stance. Emphasizing the role of innovation and macroeconomic shifts in shaping market leadership, Genua highlights the importance of identifying companies with strong R&D and the ability to adapt to changing economic conditions. He also discusses the potential impact of the US election, rising earnings, and the influx of funds from money market investments. Genua provides specific examples of companies he favors, including Nvidia for its dominance in AI chipsets, Amazon for its cloud computing prowess, Eli Lilly for its obesity drug and drug pipeline, and Cheniere Energy and Marathon for their contributions to cleaner fossil fuels and air travel, respectively.

Millions of overweight or obese Medicare patients with heart conditions may now be eligible for coverage of the popular weight-loss drug Wegovy under a new indication. The drug, approved by the FDA last month to reduce the risk of stroke and heart attack, is already covered by Medicare for people with diabetes. The Kaiser Family Foundation estimates that 3.6 million Medicare beneficiaries could be eligible for coverage of Wegovy for its new indication, but uptake may be limited by its high cost and potential side effects.

Obesity is a prevalent healthcare challenge linked to unhealthy behaviors, including poor dietary habits. Researchers have investigated how alterations in brain activity during dietary decisions impact the success of weight-loss efforts. Their findings indicate that individuals with higher body mass indices (BMIs) face reduced success rates in dietary modifications. The study highlights the significance of brain reconfiguration during dietary regulation and demonstrates that extensive changes may hinder weight loss attempts. These insights contribute to a deeper understanding of the complex relationship between brain activity, weight management, and dietary behaviors.

A comprehensive study by the Indian Council of Medical Research reveals a concerning prevalence of non-communicable metabolic diseases in various Indian states. The report, published in The Lancet Diabetes & Endocrinology, highlights the increasing prevalence of diabetes, hypertension, obesity, and dyslipidemia in India. The study’s findings emphasize the need for region-specific strategies to mitigate this growing public health issue.

Celebrity fitness trainer Jillian Michaels has weighed in on the debate surrounding trans athletes in women’s sports, saying that she believes fairness should be prioritized over inclusion. Michaels cited data showing that biological males have a significant physical advantage over biological females, even when accounting for cross-sex hormone therapy. Michaels also discussed the obesity crisis in the US, saying that it is a serious problem that needs to be addressed.

The NHS Digital Weight Management Programme, a study published in The Obesity Journal, has shown promising results with participants shedding an average of 8 pounds (3.9 kg) in just 12 weeks. Of those who completed the 12-month program, over a third were from Black, Asian, and minority ethnic backgrounds, demonstrating the program’s effectiveness for individuals facing health inequalities. The program offers tailored support based on risk levels, including self-guided digital assistance, one-on-one coaching, and group interaction sessions.

A study published in The Obesity Journal shows that thousands of people referred to the NHS Digital Weight Management Programme lost an average of half a stone in 12 weeks. The program involves diet and exercise advice and is available to adults in England with a BMI over 30 and either diabetes or high blood pressure, or with BMIs of 27.5 or more if they are from Black, Asian or minority ethnicities. Of those who started the scheme, the average weight lost was 4.85lb (2.2kg). The NHS tips for healthy weight loss include reading about healthy eating and exercise, setting realistic goals, and making gradual changes to your lifestyle.

A recent study suggests that higher dietary zinc intake may reduce the risk of asthma in overweight or obese children and adolescents. The study, published in the World Allergy Organization Journal, analyzed data from the National Health and Nutrition Examination Survey (NHANES) and found a significant inverse relationship between zinc intake and asthma occurrence. The study highlights the potential role of zinc in mitigating asthma risk in this population.

Usage of GLP-1 drugs is reducing spending at restaurants and grocery stores, impacting the food industry. Morgan Stanley projects a significant market growth for these drugs, leading to analyst expectations of increased adoption rates. Fast-casual restaurants with healthier options are expected to benefit from this shift, while fast-food chains may face increased pressure.

Weight loss plateaus are a common occurrence, particularly after about a year of dieting. The body adjusts to the calorie deficit, making it difficult to continue losing weight. Weight loss drugs and gastric bypass surgery have been shown to delay or prevent plateaus. These treatments suppress appetite and reduce the body’s ability to absorb calories, allowing individuals to maintain weight loss for longer periods.